Technology Positive

ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)

Breaking news from global financial markets

il y a 19 heures
Lire Plus
SIXUNITED Showcases Its Full-Stack AI Ecosystem at the 2025 Intel® WW LOEM Summit

SIXUNITED Showcases Its Full-Stack AI Ecosystem at the 2025 Intel® WW LOEM Summit

Technology
il y a 19 heures 3,161
Lire Plus
Registration now Open – Limited Seating for HMG Strategy’s Annual Houston Technology Leadership Summit for C-Suite Technology Executives on November 20

Registration now Open – Limited Seating for HMG Strategy’s Annual Houston Technology Leadership Summit for C-Suite Technology Executives on November 20

Technology
il y a 20 heures 1,441
Lire Plus
United States Regenerative Medicine Report 2025: Market to Reach $5.47 Bn by 2030 at a CAGR of 21.62%, Driven by Adoption of Stem Cell Technology, and a Strong Product Pipeline

United States Regenerative Medicine Report 2025: Market to Reach $5.47 Bn by 2030 at a CAGR of 21.62%, Driven by Adoption of Stem Cell Technology, and a Strong Product Pipeline

Technology
il y a 21 heures 1,133
Lire Plus
Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”

Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”

Technology
il y a 21 heures 588
Lire Plus
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Technology
il y a 21 heures 3,441
Lire Plus
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Technology
il y a 21 heures 1,083
Lire Plus
Punchcut Appoints Akshat Srivastava Director of Design Engineering

Punchcut Appoints Akshat Srivastava Director of Design Engineering

Technology
il y a 21 heures 2,801
Lire Plus
Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety

Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety

Technology
il y a 21 heures 4,573
Lire Plus
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas

BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas

Technology
il y a 21 heures 888
Lire Plus
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Technology
il y a 21 heures 2,040
Lire Plus
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Technology
il y a 21 heures 957
Lire Plus
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

Technology
il y a 21 heures 3,232
Lire Plus
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody

Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody

Technology
il y a 21 heures 3,743
Lire Plus
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025

Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025

Technology
il y a 21 heures 4,893
Lire Plus
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Technology
il y a 21 heures 1,610
Lire Plus
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

Technology
il y a 21 heures 2,591
Lire Plus
Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025

Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025

Technology
il y a 21 heures 2,106
Lire Plus
BioAge Labs to Present at Jefferies Global Healthcare Conference in London

BioAge Labs to Present at Jefferies Global Healthcare Conference in London

Technology
il y a 21 heures 2,496
Lire Plus
Aduro Clean Technologies signe une lettre d’intention pour l’installation d’une usine de démonstration en Europe

Aduro Clean Technologies signe une lettre d’intention pour l’installation d’une usine de démonstration en Europe

Technology
il y a 21 heures 3,270
Lire Plus

Tendances Actuelles

1

IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...

24,966 il y a 18 heures
2

BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...

11,189 il y a 18 heures
3

AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...

30,244 il y a 18 heures
4

BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading

9,927 il y a 18 heures
5

4Thought Technologies CEO and EY Entrepreneur of the Year Award Nominee Richie S...

9,380 il y a 18 heures

Sujets Tendance

Sentiment (24h)

Positif
175
Neutre
58
Négatif
46